The global veterinary surgical instruments market size was exhibited at USD 1.85 billion in 2023 and is projected to hit around USD 3.81 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2024 to 2033.
Report Coverage | Details |
Market Size in 2024 | USD 1.99 Billion |
Market Size by 2033 | USD 3.81 Billion |
Growth Rate From 2024 to 2033 | CAGR of 7.5% |
Base Year | 2023 |
Forecast Period | 2024-2033 |
Segments Covered | Product, Animal Type, Application, Region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Key Companies Profiled | B. Braun SE; Medtronic; Jorgen Kruuse A/S; Smiths Group plc; Neogen Corporation; STERIS; DRE Veterinary; Surgical Holdings; GerMedUSA; World Precision Instruments; Sklar Surgical Instruments; Integra LifeSciences; Im3 Inc.; Ethicon US LLC |
Increasing surgical procedures on pets in developing countries is expected to drive market growth over the forecast period. The most common products of surgical procedures on pets are dental, cataract, hip dysplasia, spay or neuter, and wound repair. According to German Research Statistics (2019), around 2.1 million surgical procedures were performed on animals in 2019. An increasing number of practitioners and technological advancements for these instruments are the major factors driving the market for veterinary surgical instruments. According to the American Veterinary Medical Association (AVMA), 124,069 veterinary practitioners were present in the U.S. as of 2023, compared to 110,531 in 2017. An increase in veterinary hospitals and clinics is further driving market growth.
Moreover, rising demand for animal health insurance, increasing adoption of companion animals, government initiatives to prevent zoonotic diseases, and new product innovation are anticipated to positively impact the growth of the market for veterinary surgical instruments. The North American Pet Health Insurance Association (NAPHIA) announced that North America’s pet insurance sector exceeded USD2.83 billion USD at year-end 2021, and industry growth more than doubled over the past four years (2018 – 2021).
Increasing incidences of periodontal problems in pets and demand for better treatment options are driving the demand for veterinary surgeries. In mixed populations of working dogs and pets, tooth fracture prevalence in dogs has been historically reported between 2.6% and 27%. Moreover, increased demand for periodontal and advanced oral surgeries has been witnessed. The availability of proper post-operative pain management treatment options is further boosting the demand for surgical intervention, subsequently driving the demand for veterinary surgical instruments.
In addition, health conditions associated with obesity are increasing, which include osteoarthritis, heart disease, dental problems, and diabetes. These conditions require surgical intervention. Major breakthroughs in veterinary practices and surgical instruments, such as advancements in orthotics and prosthetics and microfracture detection in racehorses, coupled with the adoption of simulation models in orthopedic surgeries, fuel the demand for surgeries for these conditions.
North America dominated the market with the largest revenue share of 37.9% in 2023. The rise in collective efforts taken by key players to improve their product portfolio and ensure high-quality standards is projected to boost the demand for veterinary surgical instruments in the region. For instance, in August 2018, Symmetry Surgical Inc. acquired Bovie Medical in order to improve its portfolio of veterinary electrosurgical instruments. In addition, the rising demand for pet insurance boosts market growth. According to a report published by the North American Pet Health Insurance Association (NAPHIA), more than 2.5 million pets in the U.S. and Canada were under an insurance plan as of 2018.
In addition, pet humanization and increased awareness of animal welfare are expected to fuel the Asia Pacific market over the forecast period. Japan accounted for a significant share of the regional market due to the rapid adoption of new techniques such as advanced diagnostic services and the increasing geriatric pet population. Several dogs and cats are living to a mean age of 12 to 13 years in Japan. Increasing cases of chronic disorders in animals is fueling the demand for surgical intervention. The aforementioned factors are expected to fuel the demand for veterinary surgical instruments in the coming years.
The handheld devices segment dominated the market and accounted for the largest revenue share in 2023. Handheld devices are further sub-segmented into scalpels, forceps, hooks and retractors, surgical scissors, and others. Technological advancements for these surgical instruments and increasing expenditure on animal healthcare are expected to boost segment growth. For instance, In 2023, Americans spent USD 136.8 billion on their pets, up 10.68% from USD 123.6 billion in 2021. Dog owners spend an average of USD 730 million a year on their dogs.
The electrosurgery instruments segment is expected to grow at the fastest CAGR during the forecast period due to advantages such as accuracy, easy handling, high sensitivity, and rapid healing by electrode pencils. The increasing adoption of bipolar electrosurgery instruments is also expected to drive the growth of the segment. Key industry players are taking initiatives such as mergers, acquisitions, partnerships, and collaborations in order to gain a higher market share.
The large animal segment dominated the market and accounted for the largest revenue share of 67.3% in 2023 owing to the increasing prevalence of chronic diseases of equine animals, awareness among government animal healthcare organizations, and rising expenditure on animal healthcare in developing countries. The World Health Organization (WHO) is engaging in various activities to address health threats at the human-animal-ecosystem interface including antimicrobial resistance, food-borne zoonosis, and food safety. This is expected to drive the need for better treatment facilities equipped with veterinary surgical instruments for companion animals.
The small animal segment is expected to grow at the fastest CAGR of 7.6% during the forecast period due to the increasing small animal ownership and demand for efficient animal care. According to a report by the Humane Society of the United States, around 60.2 million U.S. households had at least one dog as of 2017. The increasing rate of cranial cruciate ligament (CCL) surgeries in dogs is also expected to drive segment growth.
The dental surgery segment dominated the market and accounted for the largest revenue share in 2023, owing to increasing awareness among pet owners regarding the dental health of their pets. Moreover, increasing incidences of periodontal diseases and technological advancements in dental devices and instruments drive the growth of this segment. According to a report by the Australian and American Veterinary Dental Society, in 2020, more than 70.0% of cats and 80.0% of dogs develop gum disease at the age of three.
The orthopedic surgery segment is expected to witness lucrative growth over the forecast period due to the increasing number of animal hospitals and rising demand for orthopedic implants. For households with cats, mean annual expenditures on veterinary visits were USD 189 in 2020 and USD 321 in 2023. The mean cost of an annual wellness visit for a dog and a cat was USD 168 and USD 141 in 2016, USD 195 and USD 133 in 2020, and USD 192 and USD 169 in 2023. Initiatives by key industry players for advanced treatment options in veterinary orthopedics are fueling segment growth. For instance, in June 2018, Veterinary Orthopedic Implants launched TPLO Plate for better orthopedic implant surgeries in pets.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global veterinary surgical instruments market
Product
Animal Type
Application
Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Animal type
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Animal type outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Veterinary Surgical Instruments Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Veterinary Surgical Instruments Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Veterinary Surgical Instruments: Product Estimates & Trend Analysis
4.1. Veterinary Surgical Instruments Market: Key Takeaways
4.2. Veterinary Surgical Instruments Market: Movement & Market Share Analysis, 2024 & 2033
4.3. Handheld Devices
4.3.1. Handheld devices market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.2. Forceps
4.3.2.1. Forceps market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.3. Scalpels
4.3.3.1. Scalpels market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.4. Surgical scissors
4.3.4.1. Surgical scissors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.5. Hooks & retractors
4.3.5.1. Hooks & retractors market estimates and forecasts, 2021 to 2033 (USD Million)
4.3.6. Others
4.3.6.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
4.4. Electrosurgery Equipment
4.4.1. Electrosurgery instruments market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Sutures, Staplers and Accessories
4.5.1. Sutures, staplers and accessories market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Others
4.6.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Veterinary Surgical Instruments: Animal Type Estimates & Trend Analysis
5.1. Veterinary Surgical Instruments Market: Key Takeaways
5.2. Veterinary Surgical Instruments Market: Movement & Market Share Analysis, 2024 & 2033
5.3. Large Animals
5.3.1. Large animals market estimates and forecasts, 2021 to 2033 (USD Million)
5.4. Small Animals
5.4.1. Small animals market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Veterinary Surgical Instruments: Application Estimates & Trend Analysis
6.1. Veterinary Surgical Instruments Market: Key Takeaways
6.2. Veterinary Surgical Instruments Market: Movement & Market Share Analysis, 2024 & 2033
6.3. Soft Tissue Surgery
6.3.1. Soft tissue surgery market estimates and forecasts, 2021 to 2033 (USD Million)
6.4. Cardiovascular Surgery
6.4.1. Cardiovascular surgery market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Ophthalmic Surgery
6.5.1. Ophthalmic surgery market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Dental Surgery
6.6.1. Dental surgery market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Orthopedic Surgery
6.7.1. Orthopedic Surgery market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Veterinary Surgical Instruments Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Veterinary Surgical Instruments Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. North America market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. U.S. market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Canada market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4. Europe
7.4.1. Europe market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.2. UK
7.4.2.1. UK market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.3. Germany
7.4.3.1. Germany market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.4. France
7.4.4.1. France market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.5. Italy
7.4.5.1. Italy market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.6. Spain
7.4.6.1. Spain market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Sweden market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Norway market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.4.9. Denmark
7.4.9.1. Denmark market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.2. Japan
7.5.2.1. Japan market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.3. China
7.5.3.1. China market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.4. India
7.5.4.1. India market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.5. Australia
7.5.5.1. Australia market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.6. Thailand
7.5.6.1. Thailand market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.5.7. South Korea
7.5.7.1. South Korea market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.6. Latin America
7.6.1. Latin America market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.6.2. Brazil
7.6.2.1. Brazil market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.6.3. Mexico
7.6.3.1. Mexico market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.6.4. Argentina
7.6.4.1. Argentina market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.7. MEA
7.7.1. MEA market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Saudi Arabia market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.7.3. South Africa
7.7.3.1. South Africa market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.7.4. UAE
7.7.4.1. UAE market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
7.7.5. Kuwait
7.7.5.1. Kuwait market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. B. Braun SE
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Medtronic
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Jorgen Kruuse A/S
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Smiths Group plc
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Neogen Corporation
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. STERIS
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DRE Veterinary
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Surgical Holdings
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. GerMedUSA
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. World Precision Instruments
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Sklar Surgical Instruments
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Integra LifeSciences
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Im3 Inc.
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives
8.2.14. Ethicon US LLC
8.2.14.1. Company overview
8.2.14.2. Financial performance
8.2.14.3. Product benchmarking
8.2.14.4. Strategic initiatives